submitted Marketing Authorization

Related by string. * submitting . Submitting . submitter : - -ON SLAUGHTER DATA SUBMITTED . ON SLAUGHTER DATA SUBMITTED . submitted Biologics License / marketing . markets . market : MARKET WIRE via COMTEX . Stock Market . RBC Capital Markets / authorizations . Authorizations . AUTHORIZATION : share repurchase authorization . repurchase authorization . explicit authorization * *

Related by context. All words. (Click for frequent words.) 85 submitted Biologics License 81 Application MAA 77 submitted Marketing Authorisation 74 Submits Supplemental 73 Files IND 69 submit Biologics License 69 Initiates Enrollment 69 Submits Biologics License Application 68 Receives Orphan Drug Designation 68 Receives Positive Opinion 68 Initiates Phase III 67 Submits IND 67 highly purified pasteurized 67 Receives CE Marking 66 GTC recombinant form 66 IG HCR ;) CO 66 Crucell NV Euronext 66 submitted Premarket Approval 66 NASDAQ CRXL 66 Application BLA 66 FDA Accepts 66 Inc. www.micromet inc.com 66 Receives Approvable Letter 66 Submits NDA 65 Therapeutic Competitors Companies 65 methylnaltrexone bromide 65 Announces Tentative Approval 65 Submits Response 65 rolling Biologics License 65 Receives Fast Track 65 LSE SHP.L 65 Receives Complete Response 65 supplemental biologics 65 JOULFERON 65 Crucell NV NYSE Euronext 65 Completes Patient Enrollment 65 Raptiva R 65 Receives Tentative FDA 64 Mylan Receives Approval 64 Dynepo TM 64 liver resection surgeries 64 Initiates Phase II 64 R sorafenib tablets 64 Risperidone Oral Solution 64 Initiates Clinical 64 Nasdaq IDIX 64 assigned PDUFA 64 CAMPATH R 64 Receives Marketing Authorization 64 Granted Orphan Drug 64 Nasdaq CRXL 64 Begins Dosing 64 StaphVAX R 64 CIMZIA r 64 SIX RO ROG 64 ZALBIN 64 JAK2 Inhibitor 64 Announce License Agreement 64 ANDA Filing 63 BioSante Pharmaceuticals Announces 63 Receives Orphan Drug 63 NASDAQ SHPGY 63 Files Investigational 63 Positive Opinion 63 Psoriasis Drug 63 Orphan Drug designations 63 Receives Tentative Approval 63 Zegerid OTC 63 submitted supplemental Biologics 63 Inc. NASDAQ CVTX 63 Marketing Authorisation Application MAA 63 Silenor ® doxepin 63 Novartis VIRT X 63 Nasdaq MICU 63 Receives Milestone Payment 63 developing Zerenex ferric 63 OMP designation 62 ALLSCHWIL BASEL SWITZERLAND 62 Presents Positive Preclinical 62 successfully commercialize Iluvien 62 Initiates Clinical Trial 62 UCB Pharma SA 62 visit http:/www.mannkindcorp.com 62 Vitrasert R 62 Receive Milestone Payment 62 Launches Generic Version 62 Preotact R 62 Orphan Drug designation 62 Marketing Authorisation Application 62 SYCREST 62 Medicinal Products EMEA 62 Gets FDA Clearance 62 TRACON Pharmaceuticals 62 Marketing Authorization Application MAA 62 sitaxsentan sodium 62 Nasdaq XTLB 62 Taisho Pharmaceuticals 62 By JAMAAL ABDUL 62 Sumatriptan Succinate 62 PAION AG ISIN 62 Nasdaq TARG 62 Orphan Status 62 Peginterferon alfa 2b 62 Aloprim TM allopurinol sodium 62 NASDAQ ISTA 62 Presents Positive 62 Ready Templates 62 Fast Track Status 62 LSE SHP NASDAQ SHPGY 62 nanofiltered plasma derived 61 Generic Version 61 Rheumatoid Arthritis Drug 61 Therapeutic Competitors companiesandmarkets.com adEgemonye 61 gastrointestinal disorders characterized 61 Therapeutic Competitors Report 61 Syndrome LEMS 61 vaccine Synflorix 61 miconazole MBT 61 Nasdaq DVAX 61 License Application sBLA 61 Nasdaq PGNX 61 Dexilant 61 Nasdaq EPCT 61 Nasdaq HALO 61 Oracea ® 61 Orphan Designation 61 Vimpat ® lacosamide 61 Tibotec Therapeutics division 61 CONBRIZA 61 Patents Upheld 61 Teva Provides Update 61 gets USFDA nod 61 Horizant ™ 61 Marketing Authorization 61 commercialize oritavancin 61 Grants Orphan Drug 61 Hematide ™ peginesatide 61 Taro Receives 61 PharmaVitae Profile 61 Teikoku Pharma USA 61 Angiox ® 61 Inc. Nasdaq COLY 61 Psivida 61 label Lipofen R 61 OTCBB INSV 61 OMAPRO ™ 61 Metformin HCl 61 Renvela ® 61 SIX BSLN 61 PRAECIS PHARMACEUTICALS INCORPORATED 61 markets HP Acthar 61 Acceleron Pharma Inc. 61 OTCBB NVDL 61 PDUFA Date 61 Replagal TM 61 Pirespa 61 Nabi HB R 61 Orapred ODT 61 memantine HCl 61 Act PDUFA date 61 BRILINTA 61 Nasdaq IMGN 61 Investigational Oral 61 PSDV 61 Nabi HB Intravenous 61 Romiplostim 61 Roche OTC RHHBY 61 Partnering Agreements 61 please visit www.eisai.com 61 Oral Calcitonin 61 R lenalidomide 60 Adenuric R 60 ASX PGL 60 Actelion Ltd 60 Teikoku Seiyaku Co. 60 NASDAQ AVNR 60 Inc. OTCBB ALRX 60 TKPHF 60 Alvesco ® 60 BYETTA ® 60 nasal calcitonin product 60 Oracea TM 60 visit www.noven.com 60 Vernalis plc 60 Submits Investigational 60 NasdaqGM NTEC today 60 Enrolls First 60 Nasdaq VRTX today 60 Vidaza R 60 Nexavar tablets 60 Somatuline Depot 60 Metformin GR 60 Nasdaq NOVN 60 Zenpep 60 breast cancer pill Tykerb 60 Inc. Nasdaq SUPG 60 NASDAQ XTLB 60 Civacir 60 Lambert Eaton Myasthenic 60 Therapeutic Competitors 60 Nasdaq AVNC 60 k Premarket Notification 60 Fast Track designations 60 Fresenius Biotech 60 XIAPEX 60 Inc. NASDAQ SIRT 60 Marketing Authorization Applications 60 Receives NASDAQ 60 Mirapexin 60 Resubmits 60 refractory chronic lymphocytic 60 NASDAQ RNAI 60 Qutenza TM 60 Initiates Phase 2b 60 Demonstrates Significant 60 oxandrolone USP 60 FDA APPROVES 60 daily Glumetza TM 60 Fabre Kramer 60 rHuPH# recombinant human 60 ELIQUIS 60 Eurand NV 60 Eurand NV EURX 60 orphan medicinal product 60 Completes Enrollment 60 Biologic License Application BLA 60 Terminate Merger Agreement 60 Marketing Authorization Application 60 selective A2A adenosine receptor 60 Marketing Authorisation 60 rasagiline tablets 60 Treanda bendamustine 60 Cypress Bioscience Inc 60 OTCBB HXBM developer 60 Nasdaq VNDA 60 Aztreonam Lysine 60 Nexavar ® 60 NASDAQ BDSI 59 Keppra ® levetiracetam 59 Pharmaxis ASX PXS 59 Medicis Pharmaceutical Corp 59 Idera Pharmaceuticals 59 TSX SHQ 59 vapreotide acetate 59 Nexavar sorafenib 59 NeoRx Corporation 59 NASDAQ CGEN announced 59 Drug Candidate 59 AMEX KAL 59 Norgine BV 59 Presents Preclinical 59 Loramyc R 59 No. #.# 59 ALVESCO R 59 Abstral ® 59 Levoleucovorin 59 sapropterin dihydrochloride 59 sNDAs 59 Corp. Nasdaq BSTC 59 SpeBio joint venture 59 ALPMF 59 Pirfenidone 59 Orphan Drug status 59 ferumoxytol Injection 59 INVEGA TM 59 Recombinant Human 59 BioGlue R 59 Desvenlafaxine 59 SkyePharma Plc 59 Expanded Indication 59 AG NVS 59 hyaluronidase enzyme 59 Marketing Approval PMA 59 Advancis Pharmaceutical Corporation 59 Loramyc 59 Nasdaq AUXL 59 Nasdaq CLDX 59 Merck Serono division 59 Presents Preclinical Data 59 equine osteoarthritis marketed 59 REBETOL combination therapy 59 iloprost Inhalation Solution 59 Company Nasdaq PRGO 59 LymphoStat B TM 59 Dementia Related Psychosis 59 Marketing Authorisation Holder 59 Arthritis Drug 59 Amira Pharmaceuticals 59 Transkaryotic Therapies TKTX 59 Receives Notice Related 59 Preotact 59 Amlodipine Besylate 59 Reveals Positive 59 Idun Pharmaceuticals 59 Inc. Nasdaq IDMI 59 Generic Versions 59 Syntonix Pharmaceuticals 59 Hexvix ® 59 Somatuline R Autogel R 59 Oral BDP 59 Fujisawa Healthcare Inc. 59 Methylphenidate Transdermal System 59 Nycomed GmbH 59 Investigational Compound 59 acyclovir Lauriad R 59 pregabalin Lyrica 59 SPL# Gel vaginal microbicide 59 includes Dideco CarboMedics 59 Supplemental Biologics License Application 59 Entereg alvimopan 59 Tostrex 59 cSSTI 59 Schizophrenia Drug 59 STELARA TM 59 BOTHELL Wash. Business Wire 59 Nasdaq OSCI 59 Announce Licensing Agreement 59 Tibotec Pharmaceuticals Ltd. 59 CARBATROL 59 Nasdaq SGEN 59 Ltd. NYSE RDY 59 Inc. Nasdaq OXGN 59 Silodosin 59 Sanofi aventis EURONEXT SAN 59 hygienic cleansing 59 Increlex TM 59 Pegloticase 59 Proquin XR 59 Kuvan sapropterin dihydrochloride 59 solifenacin succinate 59 Anidulafungin 59 Initiates Clinical Trials 59 Fortigel 59 Announces Poster Presentations 59 ACOMPLIA R 59 AIM SLN 59 Generic Protonix 59 Aldara ® 59 Submits Application 59 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 59 XIAFLEX ™ 59 HAYWARD Calif. BUSINESS WIRE 59 CTRX 59 Tracleer ® bosentan 59 Milestone Payment 59 Targanta Therapeutics Corporation 59 GNLB 59 Evoltra TM 59 Biological License Application 59 mesylate tablets approved 59 Reports Preclinical Data 59 SABER ™ 59 Amex KAL 59 overactive bladder AA# 59 NASDAQ IMCL global 59 Dantrium R 59 SCHWARZ PHARMA 58 Barr ANDA 58 Elan Pharma 58 Licenses Novel 58 Desktop TEMP UPDATE idx 58 Inc. Nasdaq IMGN 58 Xyrem ® 58 supplemental Biologics License Application 58 Genelabs Technologies Inc. 58 GTC recombinant human 58 granted Orphan Designation 58 Orphan Medicinal Product 58 Delaying apoptosis may 58 Zevtera TM 58 Uvidem 58 Release Capsules 58 Esbriet ® 58 Brilique 58 ZEGERID Chewable Tablets 58 Taglich Brothers Initiates Coverage 58 Kosan Biosciences Incorporated 58 Generic Version Of 58 Inc Therapeutic Competitors 58 LUCENTIS r 58 molecular imaging radiopharmaceutical 58 include Altastaph TM 58 NYSE Amex AEN 58 Wins Patent Infringement 58 Lexiscan TM 58 Cobalt Pharmaceuticals 58 fluvoxamine maleate 58 Albugon 58 Nasdaq SPPI 58 GLOBE NEWSWIRE Cytomedix 58 Campath ® 58 5mg #mg #mg 58 Successfully Completes Phase 58 Firdapse ™ amifampridine phosphate 58 GILD GILD 58 Merck KGaA Darmstadt Germany 58 CRXL 58 Gentamicin Surgical Implant 58 Inc. Nasdaq SEPR 58 intravenous acetaminophen 58 Xcytrin R 58 Enhanze 58 Febuxostat 58 Begins Clinical Trial 58 Clinical Trials Update 58 Earns Milestone Payment 58 Tracleer r 58 Regeneron Pharma 58 COLAZAL R 58 buccal tablets 58 GATTEX TM 58 Firdapse TM amifampridine phosphate 58 Trobalt 58 Eloxatin ® 58 TELINTRA R 58 Receives Clearance 58 Raptiva ® 58 EGRIFTA 58 LSE PFZ 58 Xoma Ltd 58 Board Unanimously Rejects 58 visit smith.com 58 Stock Exchange EVT 58 RNS Number #O 58 Actemra tocilizumab 58 NASDAQ GTCB 58 Alza Corporation 58 Thrombin topical Recombinant 58 GeneraMedix Inc. 58 sorafenib tablets 58 Myrexis Inc. 58 Immunex Corporation 58 OTC IPXL 58 Orphan designation 58 TSRX 58 NASDAQ ALNY 58 Loramyc ™ 58 DRRX 58 FACTIVE ® 58 Transcept Pharmaceuticals 58 KAI Pharmaceuticals 58 NEUPOGEN R 58 PF # [002] 58 COMUNICADO DE 58 Ercole Biotech 58 Morphine Sulfate 58 Arzerra TM 58 Patent Upheld 58 Japanese Encephalitis Vaccine 58 Fludara ® 58 KAI Pharmaceuticals Inc. 58 Adenuric ® 58 Jumps Higher 58 rheumatoid arthritis psoriatic arthritis 58 Inc. Nasdaq AMGN 58 STO SOBI 58 R MSCRAMM 58 FDA Clears 58 Soliris TM eculizumab 58 ® NasdaqCM RPRX 58 NOVARTIS 58 Bradmer Pharmaceuticals 58 OLEPTRO 58 Panflu TM Sinovac 58 Esbriet pirfenidone 58 granted Ortec 58 Receives Patent 58 orphan designation 58 GTC NASDAQ GTCB 58 Ohr Pharmaceutical Inc. 58 NGSX 58 FDA Approvable Letter 58 called Microstructure Chromatograph 58 BioDelivery Sciences 58 Nasdaq ICOS 58 Orphan Drug Status 58 NYSE MRX 58 Inc. Nasdaq CRTX 58 testosterone gel LibiGel 58 Loramyc TM 58 Nasdaq MYL 58 Tramadol ER 58 European Medicines Evaluation 58 BENLYSTA ® 58 Modrenal R 58 STEDESA 58 Joulferon 57 Nasdaq CADX 57 Inc. Nasdaq CVTX 57 NASDAQ IDEV 57 Focetria 57 Anti infective 57 SPRYCEL ® 57 Handok Pharmaceuticals 57 PHRM 57 ABLYNX 57 Ambrisentan 57 Eucreas 57 PhosLo R 57 Humira adalimumab 57 mitogen activated ERK kinase 57 ATryn ® GTC recombinant 57 Unsolicited Proposal From 57 Xenazine ® 57 Liprotamase 57 Cellgate Inc. 57 Alnylam Nasdaq ALNY 57 Xyzal 57 mitoxantrone concentrate 57 please visit www.middlebrookpharma.com 57 Irinotecan Hydrochloride Injection 57 Manja Bouman CEO 57 naproxen esomeprazole magnesium 57 SUTENT ® 57 NASDAQ TRBN 57 Emezine 57 CancerVax Corporation 57 BAYRY 57 CIP TRAMADOL ER 57 Milestone Payments 57 Issued Patent 57 Announces Licensing Agreement 57 ticker CLAVIS 57 HFA MDI 57 Inhaled Insulin 57 Pandel R 57 diarrhea predominant irritable 57 Amends Agreement 57 Q4 Profit Decreases 57 Director Shareholding 57 MERREM 57 PRNewswire FirstCall Peregrine Pharmaceuticals 57 myelodysplastic myeloproliferative diseases 57 Impax ANDA 57 Pivotal Phase III 57 NASDAQ CGPI 57 ONCY 57 AFX Biopharmaceutical 57 NASDAQ TARG 57 Velaglucerase Alfa 57 Eraxis 57 BARACLUDE R 57 Drug Fails 57 calcium acetate Nabi HB 57 License Option Agreement 57 Entocort 57 AVANIR Pharmaceuticals Inc. 57 Settle Patent Litigation 57 granted orphan medicinal 57 NYSE Amex PTN 57 SHP.L 57 Kuvan TM sapropterin 57 Alitretinoin 57 histamine dihydrochloride 57 NASDAQ WCRX 57 Cholesterol Lowering Drug 57 Feraheme ® 57 HPV vaccine Cervarix 57 Retacrit 57 Insmed Incorporated NASDAQ INSM 57 Zevtera ™ 57 EMD Biosciences Inc. 57 Carbidopa Levodopa 57 Tasigna nilotinib 57 PRNewswire FirstCall BioSpecifics Technologies 57 Nasdaq NABI 57 Data Avira AntiVir 57 Nasdaq PARD 57 ticker symbol CA4 57 Osteoporosis Drug 57 Initiates Phase 57 Orphan Drug 57 Sebivo 57 MacroChem Corporation 57 Vidaza azacitidine 57 Panzem R 57 KRYSTEXXA TM pegloticase 57 Geodon ziprasidone 57 Valtropin 57 Patent Issued 57 Lung Cancer Drug 57 ILEX Oncology 57 levocetirizine 57 orally disintegrating 57 PROLOR Biotech Inc. 57 MOVIPREP ® PEG 57 Junovan TM 57 Auxilium Pharma 57 Inc. Nasdaq MITI 57 Multaq dronedarone 57 Nasdaq BSTE 57 Glybera R 57 Merz Pharma 57 Rectogesic 57 Settles Patent Litigation 57 Arzerra ofatumumab 57 Sanctura XR 57 Nasdaq HALO biopharmaceutical 57 Sanvar R 57 NASDAQ ENMD 57 Orathecin 57 Ganciclovir 57 Biophan patent 57 Brentuximab Vedotin SGN 57 Oscient Pharmaceuticals Corporation 57 sublingual tablets 57 SkyePharma PLC 57 Exelon rivastigmine 57 Orphan Drug Designation 57 PRIALT 57 OTCBB IMUC 57 Phase IIb Trial 57 Investigational Treatment 57 Receives Favorable 57 Ciclesonide 57 Biomagnetics Diagnostics Corporation 57 Present Preclinical Data 57 InvaGen 57 NerPharMa 57 Files Provisional 57 novel proprietary KL4 57 DOV Pharmaceutical 57 Patent Covering 57 Sycrest 57 ENZON 57 Nasdaq SNTS 57 RELISTOR methylnaltrexone bromide subcutaneous 57 Nasdaq VRTX 57 Inc. NASDAQ NOVC 57 Nasdaq SIGA 57 Phase 2a Trial 57 hypereosinophilic syndrome 57 Nasdaq SLXP 57 Cypher Sirolimus 57 Receives Deficiency Letter 57 Inhalation Powder 57 Xolegel 57 Accelerating apoptosis may 57 ® darbepoetin alfa 57 Apricus Bio Nasdaq APRI 57 Nasdaq PHRM 57 Morphotek ® 57 Icatibant 57 Protherics PLC 57 Xanthus Pharmaceuticals Inc. 57 Nipent R 57 FOLOTYN ® 57 Firdapse 57 Patient Enrolment 57 Restructures Operations 57 AMEX ONI 56 Transdermal Drug 56 Nasdaq MYRX 56 Thalidomide Pharmion 56 Nasdaq GNTA 56 CEPHALON 56 AERIUS 56 COLAZAL ® 56 NASDAQ OSIR 56 Glycopyrrolate 56 ABILIFY R 56 Janssen Pharmaceutica NV 56 TAXUS Element Stent System 56 Patient Enrollment 56 Vimovo 56 IMiDs R 56 NASDAQ ADLR 56 Javelin Pharma 56 IDEV Technologies 56 Rapinyl 56 Nivestim 56 Regains Full 56 Roche MabThera 56 Nasdaq OMER 56 Pharmos Corporation 56 Epilepsy Drug 56 Nasdaq CYCC 56 IMPAX Laboratories Inc. 56 OTC Zegerid 56 Ipsen Euronext IPN 56 Zalbin 56 Nasdaq ALXA announced 56 GLOBE NEWSWIRE NovaBay Pharmaceuticals 56 Nasdaq QLTI 56 Inhalation Aerosol 56 Indevus Pharma 56 MSCRAMM ® 56 www.gsk.com 56 AMEX DDD 56 BioDelivery 56 BLRX 56 PLAVIX ® 56 Luveris R Ovidrel R 56 RECOTHROM R 56 Cinryze TM maintaining 56 NASDAQ DRRX 56 Galderma Pharma 56 Awarded Qualifying Therapeutic 56 Generic Lovenox 56 NASDAQ PCYC 56 Restoraderm R 56 Combunox 56 AMEX ISV 56 Ortho Cept 56 Sunesis Pharma 56 Nasdaq MOGN 56 Ltd Therapeutic Competitors 56 Confirms Validity 56 Seasonal Influenza Vaccine 56 NASDAQ CORT 56 Announces FDA Clearance 56 cytokine immunomodulator 56 Encysive Pharma 56 AstraZeneca PLC AZN.LN 56 Nasdaq CYCC Nasdaq CYCCP 56 Nasdaq AVII 56 Genta Incorporated OTCBB GNTA 56 Emollient Foam 56 Nasdaq BJGP 56 Decentralized Procedure 56 Announces License Agreement 56 NASDAQ FLML 56 IND Filing 56 SWX BSLN 56 DAYTRANA TM 56 AMEX RGN 56 Begins Shipment 56 GLOBE NEWSWIRE OXiGENE 56 Paliperidone ER 56 Pain Neutralizer holds 56 Obtains FDA 56 novel bactericidal 56 Solzira ™ 56 Company NYSE KVa 56 ONGLYZA ™ 56 Migraine Drug 56 NasdaqGM SPPI 56 Divalproex Sodium 56 WWW browser 56 Basilea Toctino R 56 Exalgo 56 NASDAQ IPXL 56 PRNewswire FirstCall Vanda Pharmaceuticals 56 BIOTECHNOLOGY SOURCE 56 Inc. NASDAQ AGIX 56 INSPIRE Trial Phase III 56 NDA Submission 56 Portola Pharmaceuticals 56 COMBIDEX R ferumoxtran 56 Velac 56 PRNewswire FirstCall Halozyme Therapeutics 56 Decentralized Procedure DCP 56 Prostate Cancer Vaccine 56 Enters Into Licensing Agreement 56 Demonstrates Sustained 56 CDP# 56 Reexamination Certificate 56 Rectangular Column 56 Biovitrum AB 56 Plaque Psoriasis 56 Nasdaq BDSI 56 Inc. Nasdaq MYL 56 Cellegesic 56 PRNewswire FirstCall CV Therapeutics 56 Sign License Agreement 56 ONGLYZA TM 56 Catalyst Biosciences 56 Announces Adjournment 56 Gendux 56 Xarelto rivaroxaban 56 oral dual endothelin 56 Aloxi ® 56 Regains NASDAQ 56 Rotarix R 56 eprodisate KIACTA TM 56 AVASTIN 56 Ceplene ® histamine dihydrochloride 56 NASDAQ SOMX specialty 56 OTCBB DORB DOR 56 PhotoCure 56 Noxafil 56 Serdolect ® 56 UGNE 56 RoACTEMRA 56 Zirgan 56 Stedesa 56 Alfacell proprietary ribonuclease 56 Clinical Trial Results 56 ChemGenex Pharmaceuticals Limited 56 FDA Approvals 56 ABT.N Quote Profile Research 56 severe hypercholesterolemia 56 cytomegalovirus immune globulin 56 Nasdaq OSIP 56 GLOBE NEWSWIRE Vical Incorporated 56 ANDA abbreviated 56 Connetics Corporation 56 Recommends Approval 56 iPS Cell 56 Sunovion Pharmaceuticals Inc. 56 Arixtra ® 56 Merck Sante sas 56 NASDAQ SCLN 56 NASDAQ MNTA 56 AAA FWB ALT 56 novel histone deacetylase 56 lipoglycopeptide 56 ENLIGHT 56 Brovana 56 Reveals Receipt 56 NASDAQ INFI 56 DORIBAX 56 Prime Standard PA8 56 Wellstat 56 Frova ® 56 Mepact 56 Aviptadil 56 IV acetaminophen 56 AstraZeneca Iressa 56 Receives Approval From 56 OTCBB JMAR 56 QNEXA ® 56 successfully commercialize Silenor 56 Antidepressant Drug 56 Surgical Adhesive 56 Nasdaq GTCB 56 AstraZeneca Symbicort 56 Nasdaq IPXL 56 Mycamine 56 Uplyso 56 HOSPIRA 56 Nebido 56 silodosin 56 AG NOVN.VX 56 DOV Pharmaceutical Inc. 55 Bertek Pharmaceuticals 55 Torisel temsirolimus 55 CARMIEL Israel 55 Mutual Recognition Procedure 55 Sodium Injection 55 anti inflammatory NSAID 55 Paris EURONEXT CGM 55 Tykerb lapatinib 55 Inc. NASDAQ ONTY 55 DYAI 55 Voraxaze 55 NASDAQ LGND 55 Inc. NASDAQ BPAX 55 Firazyr 55 plc LSE SHP 55 NYSE Amex RNN 55 PROGENSA R 55 interferon gamma 1b 55 Fresenius Kabi AG 55 NASDAQ ENCY 55 XYZAL ® 55 Welcomes Analyst Initiation 55 NASDAQ HALO 55 ISTA Pharmaceuticals 55 Complicated Skin 55 Maxy G# 55 Inc. NASDAQ APCVZ 55 Rhucin R 55 Zytiga 55 Seikagaku 55 NASDAQ BSMD medical 55 TSX PMD 55 Amvescap PLC UK 55 desvenlafaxine 55 generic Lipitor 55 NASDAQ INGN 55 Protalix BioTherapeutics Inc 55 apomorphine hydrochloride 55 Bayer Yakuhin 55 Nasdaq THLD 55 Wyeth Torisel 55 Sprycel dasatinib 55 Terbinafine 55 aripiprazole Abilify 55 novel oral anticoagulant 55 NASDAQ CPHD 55 NYSE AMEX PLX 55 SNT MC# 55 TRANSDUR Bupivacaine 55 Acorda Therapeutics Nasdaq ACOR 55 Cefepime 55 Accelerated Assessment 55 CyDex Pharmaceuticals Inc. 55 Nasdaq ENZN 55 PrevOnco 55 NASDAQ DIGE 55 received CE Conformite 55 Schweizerhall 55 mesylate tablets 55 BNY Mellon Appointed 55 researches develops licenses 55 ticker symbol OPERA 55 NASDAQ EPIX 55 Phase III Clinical Trial 55 Adventrx Pharmaceuticals 55 Somatuline Autogel 55 Receives Unsolicited 55 Files Shelf Registration Statement 55 Pulmonary Arterial Hypertension 55 Corixa Corporation 55 FDA approvable letter 55 Clinical Trial Investigating REOLYSIN 55 Drug Eluting Stent System 55 OTCBB GNTA 55 XGEVA ™ 55 NASDAQ CXSP announced 55 EntreMed Inc. 55 Belimumab 55 Preliminary Injunction Against 55 Cimzia ® certolizumab pegol 55 Erwinase 55 exclusive sublicense 55 received CE Marking 55 Issues Complete Response 55 AMITIZA ® 55 Nasdaq SOMX specialty 55 TSX BSY 55 Xenogen Corporation 55 Rhucin ® recombinant 55 NYSE Amex ULU 55 NASDAQ PARD 55 Optaflu 55 Postpones Annual Meeting 55 ABIO 55 Afinitor ® 55 NASDAQ CRTX 55 Actavis Elizabeth 55 Nasdaq ONXX 55 NYSE Amex GTF 55 Nitoman 55 FACTIVE R gemifloxacin 55 Endo Pharmaceuticals Nasdaq ENDP 55 Inc. Nasdaq OSTE 55 REMICADE infliximab 55 Nasdaq SPEX 55 Increlex R 55 Mg Uk 55 Safinamide 55 Drug Shows Promise 55 Tesamorelin 55 Tamoxifen Citrate 55 NASDAQ ARRY 55 Amex ANX 55 RGDX 55 Adjunctive Therapy 55 casopitant 55 Voluntarily Withdraws 55 Novel Antibiotic 55 OTCBB FCSC 55 Methylnaltrexone 55 Ramelteon 55 Completes Previously Announced 55 Strattera atomoxetine 55 AIXTRON AG FSE AIX 55 Receives SFDA Approval 55 Fluconazole 55 NRGN 55 Patent Broadly Covering 55 Astex Therapeutics Limited 55 Zeneus 55 Inc SPPI 55 AstraZeneca Plc AZN 55 Bayer Nexavar 55 Praecis 55 Australian Therapeutic Goods 55 Adamis Pharmaceuticals 55 Cholesterol Drug 55 Circuit CAFC 55 Aloxi Injection 55 NEXM 55 Dalbavancin 55 OTCBB DORB 55 EndoBarrier ™ 55 Celgene Thalomid 55 Alvesco R 55 Iressa gefitinib 55 NASDAQ ALXA 55 Human Medicinal Products 55 Prestara 55 Begin Clinical Trials 55 granted Orphan Drug 55 Inc. Nasdaq NEOL 55 Extends Expiration Date 55 Aztreonam 55 EPIX Pharmaceuticals Inc. 55 NASDAQ SCRX specialty 55 Keppra XR 55 Solaraze 55 Orencia abatacept 55 Fortovase 55 Single Dose 55 pSivida Limited 55 Glatiramer Acetate 55 Zensana

Back to home page